QSZ-28101-97526
3 vaccinations
2 coded responses
12 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 105 / NY
- Registered
- 2021-04-11
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-11
Registered in v-safe
-
2021-04-11
Dose 1 — Pfizer-BioNTech
-
2021-04-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Vomiting · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-14
- 2021-04-15
- 2021-04-20
-
2021-05-02
Dose 2 — Pfizer-BioNTech
- 2021-05-16
- 2021-05-23
- 2021-05-30
- 2021-06-06
-
2021-08-02
Survey response — 3 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: Pregnancy 13 weeks 1 dayMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-11-02
-
2021-12-01
Dose 3 — Pfizer-BioNTech
- 2022-06-02
-
2022-12-01
Survey response — 12 months, dose 3MedDRA: Pregnancy — Feeling: FairFree text: Pregnant (4 months)MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-11 | Pfizer-BioNTech | |
| 2 | 2021-05-02 | Pfizer-BioNTech | |
| 3 | 2021-12-01 | Pfizer-BioNTech | No |
Free text
Release 9 — 3 months, dose 2
Symptoms: Pregnancy 13 weeks 1 day
Release 12 — 12 months, dose 3
Symptoms: Pregnant (4 months)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release